The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib - Concepedia

Concepedia

Publication | Closed Access

The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib

46

Citations

26

References

2006

Year

Cornelius Miething, Susanne Feihl, Claudia Mugler, Rebekka Grundler, Nikolas von Bubnoff, Florian Lordick, Christian Peschel, Justus Duyster

Growth AdvantageBcr-abl Mutations T315iChromatin RemodelingGeneticsMolecular GeneticsMedicineCell Biology

References

	Year	Citations

Page 1